AirCurve 11 ASV

Adaptive-Servo Ventilation therapy

AirCurve™ 11 ASV* includes a widely clinically studied adaptive-servo ventilation therapy on the market for patients presenting with central sleep apnea (CSA), obstructive sleep apnea (OSA), mixed apneas and periodic breathing. The ASV* algorithm is designed to use each patient’s unique minute ventilation and respiratory rate to deliver therapy that stabilizes ventilation for more comfortable breathing throughout the night.

* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.

Shipping costs are calculated at time of checkout by our shopping cart, based on the weight of your order and the method of shipment.